Abstract
Understanding the genetic diversity and transmission dynamics of Plasmodium falciparum, the causative agent of malaria, is crucial for effective control and elimination efforts. In some endemic regions, malaria is highly seasonal with no or little transmission during up to 8 months, yet little is known about how seasonality affects the parasite population genetics. Here we conducted a longitudinal study over 2.5 years on 1516 participants in the Upper River Region of The Gambia. With 425 P. falciparum genetic barcodes genotyped from asymptomatic infections, we developed an identity by descent (IBD) based pipeline and validated its accuracy against 199 parasite genomes sequenced from the same isolates. Genetic relatedness between isolates revealed a very low inbreeding level, suggesting continuous recombination among parasites rather than the dominance of specific strains. However, isolates from the same household were six-fold more likely to be genetically related compared to those from other villages, suggesting close transmission links within households. Seasonal variation also influenced parasite genetics, with most differentiation occurring during the transition from the low transmission season to the subsequent high transmission season. Yet chronic infections presented exceptions, including one individual who had a continuous infection by the same parasite genotype for at least 18 months. Our findings highlight the burden of asymptomatic chronic malaria carriers and the importance of characterising the parasite genetic population at the community-level. Most importantly, ‘reactive’ approaches for malaria elimination should not be limited to acute malaria cases but be broadened to households of asymptomatic carriers.
Author Summary Malaria, caused by the parasite Plasmodium falciparum, remains a significant health challenge, particularly in regions like The Gambia where transmission is seasonal. Our study explored how seasonal changes impact the genetic diversity and transmission patterns of P. falciparum within communities. By tracking 1516 participants over 2.5 years and analyzing the genetic material of the parasites they carried, we discovered that malaria parasites in this region exhibit high genetic diversity, with frequent recombination events rather than dominance by specific strains. Interestingly, we found that parasites from individuals within the same household were much more likely to be genetically related, suggesting close transmission links within households. Seasonal shifts also influenced genetic relationships, with parasite populations becoming more diverse during peak transmission periods. Notably, one individual carried the same parasite strain for over a year without showing symptoms, highlighting the hidden reservoir of chronic malaria infections. Our findings suggest that malaria control strategies should extend beyond treating symptomatic cases to include household members of infected individuals, aiming to disrupt the wider transmission network within communities. This approach could be crucial for advancing malaria elimination efforts in regions with similar transmission dynamics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by grants from the Netherlands Organization for Scientific Research (Vidi fellowship NWO 016.158.306) and the Bill & Melinda Gates Foundation (INDIE OPP1173572), the joint MRC/LSHTM fellowship, CNRS Transversales, the French National Research Agency (ANR 18‐CE15‐0009‐01), the Fondation pour la Recherche Medicale (EQU202303016290).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Gambia Government/MRC Joint Ethics Committee (SCC 1476, SCC 1318, L2015.50) and the London School of Hygiene & Tropical Medicine Ethics Committee (Ref. 10982) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Modifications to address the comments of eLife's reviewers. Supplementary figures are now located after the "References" section of the manuscript.
Data Availability
All data produced in the present work are contained in the manuscript and supplementary material.
